Wulf Dirk Leuschner

434 total citations
5 papers, 113 citations indexed

About

Wulf Dirk Leuschner is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Wulf Dirk Leuschner has authored 5 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Wulf Dirk Leuschner's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Wulf Dirk Leuschner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and CAR-T cell therapy research (2 papers). Wulf Dirk Leuschner collaborates with scholars based in Germany, France and Switzerland. Wulf Dirk Leuschner's co-authors include Werner Hoch, Dilyana Dimova, Joachim Meyer, Ercole Rao, Norbert Furtmann, Marion Schneider, Christian Lange, Magali Mathieu, Jörg Birkenfeld and Ziyu Li and has published in prestigious journals such as Journal of Biological Chemistry, Protein Engineering Design and Selection and mAbs.

In The Last Decade

Wulf Dirk Leuschner

5 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wulf Dirk Leuschner Germany 4 97 89 14 13 7 5 113
Jonas Miehling Germany 4 88 0.9× 42 0.5× 8 0.6× 4 0.3× 2 0.3× 4 116
Elena Lesca Switzerland 7 116 1.2× 92 1.0× 5 0.4× 8 0.6× 8 1.1× 7 152
Thomas Gruhl United Kingdom 2 108 1.1× 32 0.4× 11 0.8× 9 0.7× 8 1.1× 2 121
Daniel Bauer Germany 6 94 1.0× 34 0.4× 3 0.2× 4 0.3× 7 1.0× 10 124
Federica Gasparri Germany 5 211 2.2× 46 0.5× 5 0.4× 2 0.2× 7 1.0× 5 235
Rebecca F. Bhola Australia 7 136 1.4× 71 0.8× 7 0.5× 2 0.2× 2 0.3× 7 188
Amber J. Clayton United Kingdom 3 126 1.3× 95 1.1× 2 0.1× 14 1.1× 16 2.3× 3 163
Ge Yang Germany 4 76 0.8× 31 0.3× 9 0.6× 5 0.4× 25 3.6× 9 120
Yunshi Yang Sweden 4 129 1.3× 82 0.9× 10 0.7× 4 0.3× 2 0.3× 5 146
Franziska Moser Germany 3 119 1.2× 100 1.1× 4 0.3× 4 0.3× 24 3.4× 3 142

Countries citing papers authored by Wulf Dirk Leuschner

Since Specialization
Citations

This map shows the geographic impact of Wulf Dirk Leuschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wulf Dirk Leuschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wulf Dirk Leuschner more than expected).

Fields of papers citing papers by Wulf Dirk Leuschner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wulf Dirk Leuschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wulf Dirk Leuschner. The network helps show where Wulf Dirk Leuschner may publish in the future.

Co-authorship network of co-authors of Wulf Dirk Leuschner

This figure shows the co-authorship network connecting the top 25 collaborators of Wulf Dirk Leuschner. A scholar is included among the top collaborators of Wulf Dirk Leuschner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wulf Dirk Leuschner. Wulf Dirk Leuschner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Leuschner, Wulf Dirk, et al.. (2025). Impact of Light-Chain Variants on the Expression of Therapeutic Monoclonal Antibodies in HEK293 and CHO Cells. Antibodies. 14(3). 53–53. 1 indexed citations
2.
Sommerfeld, Mark, Kaj Grandien, Bodo Tillmann, et al.. (2024). Functional studies with IgM and IgA immunoglobulins: binding to pIgR, FcαμR, FcμR, and CDC activities. Apmis. 132(4). 277–288. 3 indexed citations
3.
Sjuts, Hanno, Christian Lange, Jennifer Jung, et al.. (2022). A multivalent antibody assembled from different building blocks using tag/catcher systems: a case study. Protein Engineering Design and Selection. 35. 5 indexed citations
4.
Furtmann, Norbert, Marion Schneider, Ziyu Li, et al.. (2021). An end-to-end automated platform process for high-throughput engineering of next-generation multi-specific antibody therapeutics. mAbs. 13(1). 1955433–1955433. 12 indexed citations
5.
Leuschner, Wulf Dirk & Werner Hoch. (1999). Subtype-specific Assembly of α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid Receptor Subunits Is Mediated by Their N-terminal Domains. Journal of Biological Chemistry. 274(24). 16907–16916. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026